RA Capital Management - KINNATE BIOPHARMA INC ownership

KINNATE BIOPHARMA INC's ticker is KNTE and the CUSIP is 49705R105. A total of 78 filers reported holding KINNATE BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
RA Capital Management ownership history of KINNATE BIOPHARMA INC
ValueSharesWeighting
Q1 2023$26,650,900
+2.5%
4,264,1440.0%0.60%
+14.2%
Q4 2022$26,011,278
-49.0%
4,264,1440.0%0.53%
-51.4%
Q3 2022$50,956,000
-5.2%
4,264,1440.0%1.09%
-24.2%
Q2 2022$53,771,000
+12.0%
4,264,1440.0%1.43%
+36.8%
Q1 2022$48,014,000
-24.6%
4,264,144
+18.7%
1.05%
-6.7%
Q4 2021$63,669,000
-23.0%
3,593,0520.0%1.12%
-2.0%
Q3 2021$82,712,000
-1.1%
3,593,0520.0%1.15%
-14.7%
Q2 2021$83,646,000
-25.3%
3,593,0520.0%1.34%
-20.4%
Q1 2021$111,960,000
-21.7%
3,593,0520.0%1.69%
-15.5%
Q4 2020$142,932,0003,593,0522.00%
Other shareholders
KINNATE BIOPHARMA INC shareholders Q1 2022
NameSharesValueWeighting ↓
Foresite Capital Management V, LLC 3,525,957$4,936,3407.88%
Foresite Capital Management IV, LLC 9,671,643$13,540,3007.52%
Vida Ventures Advisors, LLC 2,207,772$3,090,8814.78%
Lynx1 Capital Management LP 1,997,006$2,795,8081.85%
Nextech Invest Ltd. 2,329,480$3,261,2720.99%
Orbimed Advisors 8,009,729$11,213,6210.24%
Novo Holdings A/S 815,707$1,141,9900.08%
DAFNA Capital Management LLC 105,179$147,2510.05%
GSA CAPITAL PARTNERS LLP 374,291$5240.04%
Rock Springs Capital Management LP 405,811$568,1350.02%
View complete list of KINNATE BIOPHARMA INC shareholders